This week's Generic News includes information on the delay of the launch of generic Crestor^®, a new APCI approved vendor, and -- as always -- the latest Generics Campaign!

Additional suppliers have not yet received FDA approval to launch Generic Crestor^® (rosuvastatin), so there is a delay on this product going multi-player.

On Monday, July 11, Edenbridge launched the generic equivalent of Edecrin® (ethacrynic). The Edenbridge item will be added to the OneStop program in the A* position with visibility in McKesson Connect July 9. Estimated brand sales of Edecrin® are $89M.

This week's Generic News features the Weekly Generics Campaign along with all of APCI's discounted generics, plus a free offer from Rx Express Marketing and news from FFF Enterprises.

In this week's Generic News, learn about the new items on the Generics Campaign, reduced pricing on a number of items, and an additional OneStop rebate for ideaShare attendees!